L DOPA

L DOPA was reported 268 times

L DOPA is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SPINAL CORD HAEMATOMA 12 0.0561
1 POLYNEUROPATHY ALCOHOLIC 1 0.0526
2 VASCULAR ENCEPHALOPATHY 14 0.0493
3 INCARCERATED INCISIONAL HERNIA 1 0.0357
4 CORTICOBASAL DEGENERATION 2 0.0345
5 CONVALESCENT 1 0.0227
6 MEDICAL DEVICE SITE WARMTH 1 0.0213
7 DELUSION OF REPLACEMENT 2 0.0200
8 VASCULAR PARKINSONISM 1 0.0182
9 MALIGNANT NEOPLASM OF PLEURA 2 0.0163
10 JUVENILE MYOCLONIC EPILEPSY 1 0.0159
11 CONTRACTED BLADDER 2 0.0124
12 SOMATIC HALLUCINATION 1 0.0111
13 STOMA SITE ODOUR 2 0.0089
14 PERIORBITAL HAEMATOMA 7 0.0085
15 CAMPTOCORMIA 2 0.0083
16 STOMA SITE INFLAMMATION 6 0.0080
17 CONFUSION POSTOPERATIVE 1 0.0076
18 RETINITIS PIGMENTOSA 2 0.0076
19 GAZE PALSY 12 0.0070
20 SUBILEUS 14 0.0067
21 DELUSIONAL DISORDER, UNSPECIFIED TYPE 5 0.0067
22 HEAD CIRCUMFERENCE ABNORMAL 1 0.0065
23 SCROTAL ERYTHEMA 1 0.0060
24 DYSDIADOCHOKINESIS 1 0.0058
25 MEDICAL DEVICE SITE SWELLING 1 0.0058
26 DROPPED HEAD SYNDROME 2 0.0051
27 CRYSTAL ARTHROPATHY 1 0.0048
28 MECONIUM ASPIRATION SYNDROME 1 0.0047
29 LARYNGEAL DYSPNOEA 1 0.0044
30 CREATININE RENAL CLEARANCE ABNORMAL 2 0.0043
31 VOCAL CORD PARALYSIS 7 0.0039
32 HYPERKINESIA 8 0.0038
33 EXCESSIVE GRANULATION TISSUE 3 0.0037
34 SALIVARY GLAND NEOPLASM 1 0.0035
35 MORGANELLA INFECTION 1 0.0034
36 FAECALOMA 18 0.0033
37 ON AND OFF PHENOMENON 18 0.0032
38 PARAPROTEINAEMIA 1 0.0032
39 VENTRICULAR FAILURE 1 0.0032
40 STOMA SITE HYPERGRANULATION 2 0.0032
41 STOMA SITE INFECTION 4 0.0031
42 DROWNING 3 0.0030
43 IMPULSE-CONTROL DISORDER 6 0.0029
44 GASTROINTESTINAL SOUNDS ABNORMAL 14 0.0028
45 ABDOMINAL TENDERNESS 14 0.0028
46 PERSECUTORY DELUSION 7 0.0028
47 VASCULAR INSUFFICIENCY 1 0.0026
48 AKINESIA 5 0.0024
49 ENDOCARDITIS 12 0.0023
50 JOINT SURGERY 1 0.0023
51 DOPAMINE DYSREGULATION SYNDROME 1 0.0022
52 SALIVA ALTERED 2 0.0022
53 LOCALISED INTRAABDOMINAL FLUID COLLECTION 1 0.0022
54 FREEZING PHENOMENON 8 0.0022
55 SEXUALLY INAPPROPRIATE BEHAVIOUR 1 0.0021
56 STEREOTYPY 2 0.0021
57 INFUSION SITE HAEMATOMA 1 0.0021
58 THERAPY RESPONDER 1 0.0020
59 REDUCED FACIAL EXPRESSION 2 0.0020
60 POSTURING 1 0.0019
61 STOMA SITE DISCHARGE 5 0.0018
62 BACTERIURIA 1 0.0018
63 ENTERAL NUTRITION 1 0.0017
64 PLEOCYTOSIS 1 0.0017
65 PROTRUSION TONGUE 1 0.0017
66 GOITRE 7 0.0017
67 PARKINSONIAN GAIT 1 0.0016
68 PAROTID GLAND ENLARGEMENT 1 0.0015
69 CHONDROCALCINOSIS 1 0.0015
70 HYPERPARATHYROIDISM 3 0.0015
71 BLADDER DISORDER 14 0.0014
72 DYSLALIA 1 0.0014
73 PULMONARY SEPSIS 2 0.0014
74 OROMANDIBULAR DYSTONIA 1 0.0014
75 STOMA SITE PAIN 2 0.0014
76 CENTRAL OBESITY 1 0.0014
77 HEAT STROKE 2 0.0013
78 CHONDROCALCINOSIS PYROPHOSPHATE 1 0.0013
79 LABORATORY TEST INTERFERENCE 1 0.0013
80 POLYNEUROPATHY 15 0.0013
81 BASAL GANGLIA HAEMORRHAGE 1 0.0012
82 FEAR OF FALLING 1 0.0012
83 LEUKOCYTURIA 1 0.0012
84 ILEUS 15 0.0012
85 TONGUE MOVEMENT DISTURBANCE 1 0.0012
86 URGE INCONTINENCE 1 0.0011
87 PARKINSONISM 11 0.0011
88 GAMBLING DISORDER 3 0.0011
89 NUCHAL RIGIDITY 1 0.0011
90 ASPIRATION 12 0.0011
91 HYPERSEXUALITY 2 0.0011
92 STOMA SITE ERYTHEMA 2 0.0011
93 MICROANGIOPATHY 1 0.0011
94 ONYCHALGIA 1 0.0010
95 MOTOR DYSFUNCTION 10 0.0010
96 COMPULSIVE SHOPPING 2 0.0010
97 NAIL GROWTH ABNORMAL 1 0.0009
98 RIGHT VENTRICULAR DYSFUNCTION 1 0.0009
99 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 2 0.0009
100 PERIPHERAL SENSORY NEUROPATHY 5 0.0009
101 TONGUE HAEMORRHAGE 1 0.0009
102 BRADYKINESIA 5 0.0008
103 DEMENTIA 23 0.0008
104 OTITIS EXTERNA 1 0.0008
105 FRACTURED SACRUM 1 0.0008
106 HYPERPARATHYROIDISM SECONDARY 2 0.0008
107 WHITE MATTER LESION 1 0.0008
108 ABORTION MISSED 1 0.0008
109 ENCEPHALITIS AUTOIMMUNE 1 0.0008
110 ABNORMAL SLEEP-RELATED EVENT 1 0.0008
111 INTESTINAL DILATATION 1 0.0007
112 DYSKINESIA 30 0.0007
113 BEZOAR 1 0.0007
114 INVESTIGATION ABNORMAL 1 0.0007
115 FINE MOTOR SKILL DYSFUNCTION 2 0.0007
116 NECK INJURY 2 0.0007
117 MYOCLONUS 8 0.0007
118 CHOKING 13 0.0007
119 ADHESION 1 0.0007
120 MEAN CELL VOLUME DECREASED 1 0.0006
121 SKIN LACERATION 7 0.0006
122 RIB FRACTURE 13 0.0006
123 OCULAR DISCOMFORT 7 0.0006
124 GLYCOSYLATED HAEMOGLOBIN DECREASED 1 0.0006
125 POSTURE ABNORMAL 2 0.0006
126 BACTERIAL SEPSIS 2 0.0006
127 ILLUSION 1 0.0006
128 SPINAL FRACTURE 12 0.0006
129 METASTASES TO SPINE 2 0.0006
130 MUSCLE RIGIDITY 7 0.0006
131 CACHEXIA 3 0.0006
132 MEDICAL DEVICE REMOVAL 1 0.0006
133 THYROIDECTOMY 1 0.0006
134 NARCOLEPSY 1 0.0005
135 HYPOREFLEXIA 1 0.0005
136 COLOSTOMY 1 0.0005
137 VOCAL CORD DISORDER 1 0.0005
138 VITAMIN B12 DEFICIENCY 2 0.0005
139 TONGUE BITING 1 0.0005
140 SPINAL STENOSIS 2 0.0005
141 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 1 0.0005
142 FOETAL DISTRESS SYNDROME 1 0.0005
143 DYSTONIA 9 0.0005
144 HAEMATOMA 12 0.0005
145 BIPOLAR I DISORDER 1 0.0005
146 PARESIS 1 0.0004
147 HEAD INJURY 14 0.0004
148 SENSORY DISTURBANCE 7 0.0004
149 HALLUCINATION, VISUAL 9 0.0004
150 INTRAVENTRICULAR HAEMORRHAGE 1 0.0004
151 HYPOTONIA 4 0.0004
152 EOSINOPHILIA 7 0.0004
153 WHITE BLOOD CELL COUNT INCREASED 15 0.0004
154 CLUMSINESS 1 0.0004
155 OESOPHAGEAL STENOSIS 1 0.0004
156 UPPER RESPIRATORY TRACT CONGESTION 1 0.0003
157 BLOOD PARATHYROID HORMONE INCREASED 1 0.0003
158 NEUROLEPTIC MALIGNANT SYNDROME 4 0.0003
159 TYPE 1 DIABETES MELLITUS 2 0.0003
160 CEREBROVASCULAR DISORDER 1 0.0003
161 INGUINAL HERNIA 2 0.0003
162 SELF INJURIOUS BEHAVIOUR 1 0.0003
163 MASTICATION DISORDER 1 0.0003
164 CONCOMITANT DISEASE AGGRAVATED 2 0.0003
165 HYPERCALCAEMIA 4 0.0003
166 OLIGURIA 2 0.0003
167 INJECTION SITE INFECTION 1 0.0003
168 CEREBRAL HAEMATOMA 1 0.0003
169 CERVICAL VERTEBRAL FRACTURE 1 0.0003
170 FIBRIN D DIMER INCREASED 1 0.0003
171 DEVICE PLACEMENT ISSUE 1 0.0003
172 HYPOKINESIA 4 0.0003
173 PARADOXICAL DRUG REACTION 1 0.0003
174 COMMUNICATION DISORDER 1 0.0003
175 CLAVICLE FRACTURE 1 0.0003
176 OESOPHAGEAL DISORDER 1 0.0003
177 DELIRIUM 9 0.0003
178 THERAPEUTIC PRODUCT EFFECT VARIABLE 1 0.0003
179 DELUSION 4 0.0003
180 SPLENOMEGALY 3 0.0003
181 SLEEP DISORDER 18 0.0003
182 RESPIRATORY ACIDOSIS 1 0.0003
183 CEREBRAL ATROPHY 1 0.0003
184 CREATININE RENAL CLEARANCE DECREASED 1 0.0002
185 APPLICATION SITE DISCOLOURATION 1 0.0002
186 PSYCHOMOTOR HYPERACTIVITY 4 0.0002
187 PNEUMONIA ASPIRATION 6 0.0002
188 MOBILITY DECREASED 17 0.0002
189 ESCHERICHIA URINARY TRACT INFECTION 1 0.0002
190 INFLAMMATION 12 0.0002
191 OCULAR ICTERUS 1 0.0002
192 IMMOBILE 1 0.0002
193 TONGUE DISCOLOURATION 1 0.0002
194 DYSPHEMIA 1 0.0002
195 PANCREATITIS 12 0.0002
196 HALLUCINATION 17 0.0002
197 LUMBAR VERTEBRAL FRACTURE 1 0.0002
198 YELLOW SKIN 1 0.0002
199 SKIN REACTION 3 0.0002
200 HUMERUS FRACTURE 1 0.0002
201 APATHY 3 0.0002
202 ERYSIPELAS 1 0.0002
203 TOXIC ENCEPHALOPATHY 1 0.0002
204 CEREBRAL ISCHAEMIA 1 0.0002
205 COGNITIVE DISORDER 9 0.0002
206 RESPIRATORY FAILURE 14 0.0002
207 GENERAL PHYSICAL HEALTH DETERIORATION 22 0.0002
208 POLYARTHRITIS 1 0.0002
209 BREAST CANCER METASTATIC 2 0.0002
210 BEHAVIOUR DISORDER 1 0.0002
211 SKIN ATROPHY 1 0.0002
212 SPEECH DISORDER 9 0.0002
213 METASTASES TO LIVER 3 0.0002
214 URINE ODOUR ABNORMAL 1 0.0002
215 PROTHROMBIN TIME PROLONGED 1 0.0002
216 HEPATIC FAILURE 5 0.0002
217 DYSARTHRIA 6 0.0002
218 THERAPEUTIC RESPONSE CHANGED 1 0.0002
219 RENAL IMPAIRMENT 13 0.0002
220 ABDOMINAL DISTENSION 16 0.0002
221 IMMUNE SYSTEM DISORDER 2 0.0002
222 DYSPHAGIA 14 0.0001
223 TACHYPNOEA 2 0.0001
224 EYE MOVEMENT DISORDER 1 0.0001
225 RESPIRATION ABNORMAL 1 0.0001
226 JOINT EFFUSION 1 0.0001
227 DEVICE USE ERROR 5 0.0001
228 DEVICE OCCLUSION 2 0.0001
229 PULMONARY ARTERIAL HYPERTENSION 2 0.0001
230 MENTAL DISORDER 6 0.0001
231 GAMMA-GLUTAMYLTRANSFERASE INCREASED 3 0.0001
232 CEREBRAL DISORDER 1 0.0001
233 CATARACT 8 0.0001
234 HALLUCINATION, AUDITORY 2 0.0001
235 MIOSIS 1 0.0001
236 SENSORY LOSS 1 0.0001
237 RHINITIS 1 0.0001
238 DECUBITUS ULCER 1 0.0001
239 ASPHYXIA 1 0.0001
240 SPINAL COMPRESSION FRACTURE 1 0.0001
241 AGGRESSION 6 0.0001
242 INFUSION SITE ERYTHEMA 1 0.0001
243 CIRCULATORY COLLAPSE 2 0.0001
244 NIGHTMARE 4 0.0001
245 DEVICE DISLOCATION 5 0.0001
246 DRUG EFFECT DECREASED 6 0.0001
247 MIDDLE INSOMNIA 2 0.0001
248 URINARY INCONTINENCE 3 0.0001
249 DEPRESSED LEVEL OF CONSCIOUSNESS 4 0.0001
250 EMBEDDED DEVICE 1 0.0001
251 SALIVARY HYPERSECRETION 1 0.0001
252 APHASIA 3 0.0001
253 INITIAL INSOMNIA 1 0.0001
254 EAR DISCOMFORT 1 0.0001
255 HELICOBACTER INFECTION 1 0.0001
256 FALL 32 0.0001
257 TENDERNESS 1 0.0001
258 JOINT DISLOCATION 1 0.0001
259 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
260 OESOPHAGITIS 1 0.0001
261 WOUND INFECTION 1 0.0001
262 BLOOD GLUCOSE FLUCTUATION 1 0.0001
263 THERAPEUTIC RESPONSE SHORTENED 3 0.0001
264 HYPERTENSIVE CRISIS 1 0.0001
265 PANCREATITIS ACUTE 2 0.0001
266 FISTULA 1 0.0001
267 TRANSIENT ISCHAEMIC ATTACK 3 0.0001
268 CHROMATURIA 2 0.0001
269 IMPAIRED DRIVING ABILITY 1 0.0001
270 MYOCARDIAL ISCHAEMIA 1 0.0001
271 UNINTENTIONAL MEDICAL DEVICE REMOVAL 1 0.0001
272 SWELLING 8 0.0001
273 SPINAL PAIN 1 0.0001
274 NOCTURIA 1 0.0001
275 MUSCLE SPASTICITY 1 0.0001
276 BALANCE DISORDER 7 0.0001
277 GLYCOSYLATED HAEMOGLOBIN INCREASED 2 0.0001
278 MUSCLE ATROPHY 1 0.0001
279 HAEMATEMESIS 2 0.0001
280 MYDRIASIS 1 0.0001
281 UNRESPONSIVE TO STIMULI 2 0.0001
282 ABDOMINAL PAIN 18 0.0001
283 JOINT STIFFNESS 2 0.0001
284 JOINT RANGE OF MOTION DECREASED 1 0.0001
285 MOOD ALTERED 2 0.0001
286 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
287 MENTAL STATUS CHANGES 2 0.0001
288 LYMPHOPENIA 1 0.0001
289 MULTIPLE ORGAN DYSFUNCTION SYNDROME 2 0.0001
290 MUSCULAR WEAKNESS 8 0.0001
291 SUBDURAL HAEMATOMA 1 0.0001
292 PARALYSIS 1 0.0001
293 BLOOD CREATINE PHOSPHOKINASE INCREASED 2 0.0001
294 ASCITES 2 0.0001
295 TREMOR 11 0.0001
296 DRUG DISPENSING ERROR 1 0.0001
297 HIP ARTHROPLASTY 1 0.0001
298 LIMB DISCOMFORT 2 0.0001
299 THERAPY PARTIAL RESPONDER 1 0.0001
300 BRAIN FOG 1 0.0001
301 MOOD SWINGS 2 0.0001
302 PHOTOSENSITIVITY REACTION 1 0.0001
303 DRUG LEVEL INCREASED 1 0.0001
304 GAIT INABILITY 2 0.0001
305 BLOOD UREA INCREASED 1 0.0001
306 UPPER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
307 HAEMATURIA 2 0.0001
308 PARANOIA 1 0.0001
309 ORTHOSTATIC HYPOTENSION 1 0.0001
310 DEPRESSED MOOD 3 0.0001
311 HEAD DISCOMFORT 1 0.0001
312 ISCHAEMIC STROKE 1 0.0001
313 CEREBRAL HAEMORRHAGE 2 0.0001
314 LEUKOCYTOSIS 1 0.0001
315 DRUG EFFECT INCOMPLETE 2 0.0001
316 C-REACTIVE PROTEIN INCREASED 2 0.0001
317 RESTLESSNESS 2 0.0001
318 SOMNOLENCE 11 0.0001
319 CONJUNCTIVITIS 1 0.0001
320 AGRANULOCYTOSIS 1 0.0001
321 FRACTURE 1 0.0001
322 GAIT DISTURBANCE 10 0.0001
323 PULMONARY FIBROSIS 1 0.0001
324 NEUTROPENIA 7 0.0001
325 PLASMA CELL MYELOMA 2 0.0001
326 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
327 DISORIENTATION 2 0.0001
328 PRESCRIBED UNDERDOSE 1 0.0001
329 FEEDING DISORDER 1 0.0000
330 TASTE DISORDER 1 0.0000
331 OEDEMA PERIPHERAL 6 0.0000
332 BODY TEMPERATURE INCREASED 1 0.0000
333 EATING DISORDER 1 0.0000
334 LOSS OF CONSCIOUSNESS 6 0.0000
335 RECTAL HAEMORRHAGE 2 0.0000
336 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
337 FAECES DISCOLOURED 1 0.0000
338 AMNESIA 3 0.0000
339 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
340 DEPRESSION 10 0.0000
341 SHOCK 1 0.0000
342 MUSCLE TWITCHING 1 0.0000
343 SEIZURE 5 0.0000
344 PERICARDIAL EFFUSION 1 0.0000
345 LIVER INJURY 1 0.0000
346 EXTRAPYRAMIDAL DISORDER 1 0.0000
347 CARDIOVASCULAR DISORDER 1 0.0000
348 MALIGNANT NEOPLASM PROGRESSION 4 0.0000
349 DIZZINESS 19 0.0000
350 JAUNDICE 1 0.0000
351 DISTURBANCE IN ATTENTION 2 0.0000
352 COMPLETED SUICIDE 3 0.0000
353 TARDIVE DYSKINESIA 1 0.0000
354 LETHARGY 2 0.0000
355 DRUG WITHDRAWAL SYNDROME 3 0.0000
356 LABORATORY TEST ABNORMAL 1 0.0000
357 DEVICE ISSUE 3 0.0000
358 RESPIRATORY DISORDER 1 0.0000
359 ILL-DEFINED DISORDER 2 0.0000
360 CONDITION AGGRAVATED 10 0.0000
361 PLEURAL EFFUSION 2 0.0000
362 DRUG ADMINISTRATION ERROR 1 0.0000
363 ALANINE AMINOTRANSFERASE INCREASED 2 0.0000
364 FEMUR FRACTURE 1 0.0000
365 BREAST CANCER 3 0.0000
366 EXPOSURE DURING PREGNANCY 2 0.0000
367 PRODUCT USE ISSUE 6 0.0000
368 DRUG-INDUCED LIVER INJURY 1 0.0000
369 INTENTIONAL OVERDOSE 2 0.0000
370 RHINORRHOEA 2 0.0000
371 CONFUSIONAL STATE 5 0.0000
372 ATRIAL FIBRILLATION 3 0.0000
373 URINARY RETENTION 1 0.0000
374 EYE PRURITUS 1 0.0000
375 HYPOXIA 1 0.0000
376 DYSPNOEA 16 0.0000
377 PRODUCT ADHESION ISSUE 1 0.0000
378 CONSTIPATION 6 0.0000
379 UNDERDOSE 2 0.0000
380 MUSCLE SPASMS 5 0.0000
381 AGITATION 2 0.0000
382 ASTHENIA 10 0.0000
383 INTESTINAL OBSTRUCTION 1 0.0000
384 NAUSEA 20 0.0000
385 ABNORMAL BEHAVIOUR 1 0.0000
386 CARDIAC FAILURE 2 0.0000
387 RHABDOMYOLYSIS 1 0.0000
388 POLLAKIURIA 1 0.0000
389 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
390 WITHDRAWAL SYNDROME 1 0.0000
391 TOXICITY TO VARIOUS AGENTS 4 0.0000
392 HYPERHIDROSIS 3 0.0000
393 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
394 INSOMNIA 6 0.0000
395 TACHYCARDIA 2 0.0000
396 THERAPY NON-RESPONDER 1 0.0000
397 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
398 OCULAR HYPERAEMIA 1 0.0000
399 DISEASE RECURRENCE 1 0.0000
400 SYNCOPE 2 0.0000
401 CELLULITIS 1 0.0000
402 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 4 0.0000
403 FLUID RETENTION 1 0.0000
404 THERAPY CESSATION 1 0.0000
405 HAEMOGLOBIN DECREASED 2 0.0000
406 PERIPHERAL SWELLING 3 0.0000
407 MUSCULOSKELETAL PAIN 1 0.0000
408 PARAESTHESIA 3 0.0000
409 DRUG INTERACTION 3 0.0000
410 OFF LABEL USE 16 0.0000
411 ARTHROPATHY 1 0.0000
412 FATIGUE 14 0.0000
413 INFLUENZA 2 0.0000
414 SEPSIS 2 0.0000
415 NECK PAIN 1 0.0000
416 THROMBOCYTOPENIA 2 0.0000
417 COUGH 5 0.0000
418 OXYGEN SATURATION DECREASED 1 0.0000
419 FLATULENCE 1 0.0000
420 PRODUCT SUBSTITUTION ISSUE 1 0.0000
421 BACK PAIN 4 0.0000
422 BONE PAIN 1 0.0000
423 SURGERY 1 0.0000
424 DISEASE PROGRESSION 2 0.0000
425 IRRITABILITY 1 0.0000
426 THERAPEUTIC RESPONSE DECREASED 1 0.0000
427 SUICIDE ATTEMPT 1 0.0000
428 VERTIGO 1 0.0000
429 DRUG INEFFECTIVE 21 0.0000
430 SWELLING FACE 1 0.0000
431 PRODUCT DOSE OMISSION 1 0.0000
432 BLOOD CREATININE INCREASED 1 0.0000
433 HEPATIC ENZYME INCREASED 1 0.0000
434 MEMORY IMPAIRMENT 2 0.0000
435 INJURY 1 0.0000
436 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
437 OVERDOSE 3 0.0000
438 PAIN 8 0.0000
439 HOSPITALISATION 2 0.0000
440 DECREASED APPETITE 3 0.0000
441 HEADACHE 8 0.0000
442 PNEUMONIA 4 0.0000
443 INFLUENZA LIKE ILLNESS 1 0.0000
444 PRODUCT USE IN UNAPPROVED INDICATION 3 0.0000
445 DRUG DOSE OMISSION 2 0.0000
446 CEREBROVASCULAR ACCIDENT 2 0.0000
447 URINARY TRACT INFECTION 2 0.0000
448 DEATH 10 0.0000
449 PYREXIA 4 0.0000
450 MUSCULOSKELETAL STIFFNESS 1 0.0000
451 ADVERSE DRUG REACTION 1 0.0000
452 SUICIDAL IDEATION 1 0.0000
453 NASOPHARYNGITIS 2 0.0000
454 WEIGHT DECREASED 3 0.0000
455 ANXIETY 3 0.0000
456 PULMONARY EMBOLISM 1 0.0000
457 CONTUSION 1 0.0000
458 DRUG INTOLERANCE 1 0.0000
459 PAIN IN EXTREMITY 3 0.0000
460 DYSPEPSIA 1 0.0000
461 HYPOTENSION 2 0.0000
462 ERYTHEMA 2 0.0000
463 ARTHRALGIA 4 0.0000
464 HYPERTENSION 2 0.0000
465 INCORRECT DOSE ADMINISTERED 2 0.0000
466 FEELING ABNORMAL 2 0.0000
467 JOINT SWELLING 1 0.0000
468 VISUAL IMPAIRMENT 1 0.0000
469 DRY SKIN 1 0.0000
470 PRODUCT QUALITY ISSUE 1 0.0000
471 VISION BLURRED 1 0.0000
472 ACUTE KIDNEY INJURY 1 0.0000
473 VOMITING 3 0.0000
474 DIARRHOEA 4 0.0000
475 COVID-19 1 0.0000
476 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
477 NO ADVERSE EVENT 1 0.0000
478 BLOOD GLUCOSE INCREASED 1 0.0000
479 ANAEMIA 1 0.0000
480 PRURITUS 2 0.0000
481 ABDOMINAL PAIN UPPER 1 0.0000
482 MALAISE 2 0.0000
483 WEIGHT INCREASED 1 0.0000